Robert Soiffer, a professor of medicine at the Harvard Medical School, has been nominated to the supervisory board of Kiadis Pharma NV. Dr Soiffer is chief of the division of haematologic malignancies at the Dana-Farber Cancer Institute, which includes co-directing the adult stem cell transplantation programme.
Concurrently, Berndt Modig has also been nominated to the board. Mr Modig is a certified public accountant with more than 30 years of experience in finance, including operations management and audit.
Kiadis Pharma announced the appointments on 7 April 2016.
Copyright 2016 Evernow Publishing Ltd